title: An unusual case of a borderline Brenner tumor associated with bilateral serous cystadenoma and endometrial carcinoma.
abstract: Brenner tumor accounts for 1.5 to 2.5% of ovarian tumors. Nearly all are benign and 1% malignant. Less than twenty-five cases of borderline Brenner tumor have been reported worldwide. Our case is the first one related to a bilateral ovarian serous cystadenofibroma and endometrioid adenocarcinoma. This unusual case increases the limited data for borderline Brenner tumors.
authors.forename: Daniel
authors.initials: D
authors.lastname: Cruz-Galarza
authors.forename: Omar
authors.initials: O
authors.lastname: Pérez-Rodríguez
authors.forename: Joaquín
authors.initials: J
authors.lastname: Laboy-Torres
authors.forename: Silvia
authors.initials: S
authors.lastname: Gutiérrez-Rivera
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D001943:Breast Neoplasms / Q000188:drug therapy / Q000601:surgery; D001948:Brenner Tumor / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy / Q000601:surgery; D003131:Combined Modality Therapy; D018293:Cystadenoma, Serous / Q000473:pathology* / Q000601:surgery; D016889:Endometrial Neoplasms / Q000139:chemically induced / Q000209:etiology / Q000473:pathology* / Q000601:surgery; D004967:Estrogens / Q000378:metabolism; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008875:Middle Aged; D009376:Neoplasms, Hormone-Dependent / Q000139:chemically induced / Q000209:etiology / Q000473:pathology* / Q000601:surgery; D009378:Neoplasms, Multiple Primary / Q000473:pathology* / Q000601:surgery; D016609:Neoplasms, Second Primary / Q000139:chemically induced / Q000473:pathology / Q000601:surgery; D010048:Ovarian Cysts / Q000150:complications; D010051:Ovarian Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D010052:Ovariectomy; D058994:Salpingectomy; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D004967:Estrogens; D013629:Tamoxifen